These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 28150140

  • 21. [Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program].
    Ostroumova OD.
    Ter Arkh; 2017; 89(8):29-36. PubMed ID: 28914848
    [Abstract] [Full Text] [Related]

  • 22. Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects.
    Mazza A, Townsend DM, Schiavon L, Torin G, Lenti S, Rossetti C, Rigatelli G, Rubello D.
    Biomed Pharmacother; 2019 Dec; 120():109539. PubMed ID: 31627089
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM, Schaefer A.
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [Abstract] [Full Text] [Related]

  • 24. Perindopril/amlodipine (Prestalia(®)): a review in hypertension.
    Shirley M, McCormack PL.
    Am J Cardiovasc Drugs; 2015 Oct; 15(5):363-70. PubMed ID: 26341621
    [Abstract] [Full Text] [Related]

  • 25. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Oct; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 26. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
    Tóth K, PIANIST Investigators.
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):137-45. PubMed ID: 24590580
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH, Jeon HK, Cha TJ, Hong TJ, Kim SH, Lee NH, Yoon JH, Yoon N, Hwang KK, Jo SH, Youn HJ.
    Drug Des Devel Ther; 2016 Apr; 10():3817-3826. PubMed ID: 27920497
    [Abstract] [Full Text] [Related]

  • 28. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G, I-COMBINE Study Investigators.
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy.
    Hu D, Sun Y, Liao Y, Huang J, Zhao R, Yang K.
    Cardiology; 2016 Aug; 134(1):1-10. PubMed ID: 26771522
    [Abstract] [Full Text] [Related]

  • 30. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 Aug; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 31. Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.
    Hatala R, Pella D, Hatalová K, Šidlo R.
    Clin Drug Investig; 2012 Sep 01; 32(9):603-12. PubMed ID: 22877321
    [Abstract] [Full Text] [Related]

  • 32. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M.
    Am J Hypertens; 2004 Jun 01; 17(6):495-501. PubMed ID: 15177521
    [Abstract] [Full Text] [Related]

  • 33. [Efficacy and Safety of a Fixed Combination of Perindopril Arginine and Amlodipine in Patients With Hypertension Uncontrolled by Treatment With Angiotensin II Receptor Blockers in Real Clinical Practice. Results of the PREVOSHODSTVO (SUPERIORITY) Program].
    Ostroumova OD.
    Kardiologiia; 2017 Jan 01; (1):30-36. PubMed ID: 28290831
    [Abstract] [Full Text] [Related]

  • 34. Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.
    Hatalova K, Pella D, Sidlo R, Hatala R.
    Clin Drug Investig; 2016 Jul 01; 36(7):591-8. PubMed ID: 27113228
    [Abstract] [Full Text] [Related]

  • 35. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ, Lameira D, Guillausseau PJ.
    Vasc Health Risk Manag; 2008 Jul 01; 4(2):443-51. PubMed ID: 18561520
    [Abstract] [Full Text] [Related]

  • 36. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G, I-ADD Study Investigators.
    Clin Ther; 2012 Aug 01; 34(8):1720-34.e3. PubMed ID: 22853847
    [Abstract] [Full Text] [Related]

  • 37. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension.
    Karpov Y, Dongre N, Vigdorchik A, Sastravaha K.
    Adv Ther; 2012 Feb 01; 29(2):134-47. PubMed ID: 22271158
    [Abstract] [Full Text] [Related]

  • 38. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM, Yan LR, Tao YK, Wang L, Li YQ, Gao MM, Wang YN, Li CX, Wang XW, Lu XL, Pang HM, Li YS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan 01; 39(1):57-60. PubMed ID: 21418799
    [Abstract] [Full Text] [Related]

  • 39. Short-Term Cardioprotective Effects of the Original Perindopril/Amlodipine Fixed-Dose Combination in Patients with Stable Coronary Artery Disease: Results of the PAPA-CAD Study.
    Forster T, Dézsi CA.
    Adv Ther; 2016 Oct 01; 33(10):1771-1781. PubMed ID: 27475811
    [Abstract] [Full Text] [Related]

  • 40. Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
    Ionescu DD, PREFER Investigators.
    Clin Drug Investig; 2009 Oct 01; 29(12):767-76. PubMed ID: 19888783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.